+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Therapeutic Respiratory Devices Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon


  • 213 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5754647
The Global Therapeutic Respiratory Devices Market is estimated to be USD 19.88 Bn in 2023 and is expected to reach USD 41.37 Bn by 2028 growing at a CAGR of 15.78%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Therapeutic Respiratory Devices Market is segmented based on Product, Disease Indication, Disposable, End User and Geography.
  • By Product, the market is classified into Positive Airway Pressure (PAP)Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, Reusable Resuscitators, Nitric Oxide Delivery Units, and Oxygen Hoods.
  • By Disease Indication, the market is classified into Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchitis, Sleep Apnea, and Other Diseases.
  • By Disposable, the market is classified into Masks, Breathing Circuits, and Other Disposables.
  • By End User, the market is classified into Hospitals, Homecare Settings, Emergency Health Services, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Asahi Kasei Corp., Becton, Dickinson, and Company, DeVilbiss Healthcare LLC, Draegerwerk Ag and CO. KGAA, Fisher & Paykel Healthcare Ltd., GE Healthcare, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Therapeutic Respiratory Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Therapeutic Respiratory Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Therapeutic Respiratory Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.1.2 Increased Rate of Chronic Respiratory Diseases
4.1.3 High Prevalence of Tobacco Smoking
4.2 Restraints
4.2.1 High Cost of Devices
4.2.2 Patients Depend on Reimbursements for Treatment
4.2.3 Stringent Regulations on Device Approvals
4.3 Opportunities
4.3.1 Technological Advancements and Increasing Applications in Homecare Settings
4.3.2 Introduction of Real-Time Respiratory Monitoring Devices
4.4 Challenges
4.4.1 Lower Awareness Rate among People about Respiratory Infectious Diseases
4.4.2 Huge Number of Lung-Related Diseases are Still Underdiagnosed and Undertreated
4.4.3 Lack of Patient Compliance
4.4.4 Harmful Effects of Certain Devices on Neonates
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Therapeutic Respiratory Devices Market, By Product
6.1 Introduction
6.2 Positive Airway Pressure (PAP)Devices
6.2.1 CPAP Devices
6.2.2 APAP Devices
6.2.3 BiPAP Devices
6.3 Humidifiers
6.3.1 Heated Humidifiers
6.3.2 Passover Humidifiers
6.4 Nebulizers
6.4.1 Compressor-Based Nebulizers
6.4.2 Piston-Based Hand-Held Nebulizers
6.4.3 Ultrasonic Nebulizers
6.5 Oxygen Concentrators
6.5.1 Fixed Oxygen Concentrators
6.5.2 Portable Oxygen Concentrators
6.6 Ventilators
6.6.1 ICU Ventilators High-End Ventilators Mid-End Ventilators Basic Ventilators
6.6.2 Portable/Transportable Ventilators
6.7 Inhalers
6.7.1 Metered-Dose Inhalers (MDIs)
6.7.2 Dry Powder Inhalers (DPIs)
6.8 Reusable Resuscitators
6.9 Nitric Oxide Delivery Units
6.10 Oxygen Hoods
7 Global Therapeutic Respiratory Devices Market, By Disease Indication
7.1 Introduction
7.2 Chronic Obstructive Pulmonary Disease (COPD)
7.3 Asthma
7.4 Bronchitis
7.5 Sleep Apnea
7.6 Other Diseases
8 Global Therapeutic Respiratory Devices Market, By Disposable
8.1 Introduction
8.2 Breathing Circuits
8.3 Masks
8.4 Other Disposables
9 Global Therapeutic Respiratory Devices Market, By End User
9.1 Introduction
9.2 Emergency Health Services
9.3 Homecare Settings
9.4 Hospitals
9.5 Others
10 Americas' Therapeutic Respiratory Devices Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's Therapeutic Respiratory Devices Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa's Therapeutic Respiratory Devices Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC's Therapeutic Respiratory Devices Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 ACare Technology Co., Ltd.
15.2 Asahi Kasei Corp.
15.3 Bayer Ag
15.4 Becton, Dickinson, and Company
15.5 BMC Medical Co., Ltd.
15.6 CAIRE, Inc.
15.7 Chart Industries, Inc.
15.8 Compumedics Ltd.
15.9 DeVilbiss Healthcare LLC
15.10 Dragerwerk Ag And CO. KGAA
15.11 F. Hoffmann-La Roche Ltd.
15.12 Fisher & Paykel Healthcare Ltd.
15.13 GE Healthcare
15.14 Getinge AB
15.15 GlaxoSmithKline PLC
15.16 Hill-Rom Holdings, Inc.
15.17 ICU Medical, Inc.
15.18 Inogen, Inc.
15.19 Invacare Corp.
15.20 Koninklijke Philips N.V.
15.21 Masimo Corp.
15.22 Medtronic PLC
15.23 Mindray Medical International Ltd.
15.24 Nidek Medical Products, Inc.
15.25 Nihon Kohden Corp.
15.26 Philips Healthcare
15.27 ResMed, Inc.
15.28 Rotech Healthcare, Inc.
15.29 Smith’s Group PLC
15.30 Vyaire Medical, Inc.
16 Appendix
16.1 Questionnaire

Companies Mentioned

  • ACare Technology Co., Ltd.
  • Asahi Kasei Corp.
  • Bayer Ag
  • Becton, Dickinson, and Company
  • BMC Medical Co., Ltd.
  • CAIRE, Inc.
  • Chart Industries, Inc.
  • Compumedics Ltd.
  • DeVilbiss Healthcare LLC
  • Dragerwerk Ag And CO. KGAA
  • F. Hoffmann-La Roche Ltd.
  • Fisher & Paykel Healthcare Ltd.
  • GE Healthcare
  • Getinge AB
  • GlaxoSmithKline PLC
  • Hill-Rom Holdings, Inc.
  • ICU Medical, Inc.
  • Inogen, Inc.
  • Invacare Corp.
  • Koninklijke Philips N.V.
  • Masimo Corp.
  • Medtronic PLC
  • Mindray Medical International Ltd.
  • Nidek Medical Products, Inc.
  • Nihon Kohden Corp.
  • Philips Healthcare
  • ResMed, Inc.
  • Rotech Healthcare, Inc.
  • Smith’s Group PLC
  • Vyaire Medical, Inc.